Why I Use GeneSight® Testing in My Practice: more than A Decade of Experience with Precision Psychiatry

If you’ve ever taken a psychiatric medication that didn’t work—or experienced frustrating side effects—you know how discouraging the process of finding the right treatment can feel. One of the questions I hear most often is, “Is there any way to know which medication will work best for me?”

While no test can predict with 100% certainty which medication will be the perfect fit, GeneSight® testing has become one of the most valuable tools I use to help guide medication decisions.

In fact, I’ve served as a GeneSight consultant for more than 10 years, educating healthcare providers on pharmacogenomics and helping clinicians understand how genetic information can be integrated into psychiatric care. Over the past decade, I’ve seen firsthand how this technology has evolved and how it can help clinicians make more informed prescribing decisions.

What Is GeneSight?

GeneSight is a pharmacogenomic test that analyzes specific genes involved in how your body metabolizes and responds to many commonly prescribed psychiatric medications.

Using a simple cheek swab, the test evaluates important genes—including CYP2D6 and CYP2C19—that influence how quickly or slowly your body processes certain antidepressants, anxiety medications, mood stabilizers, and antipsychotics.

Rather than relying solely on trial and error, GeneSight provides additional information that helps clinicians personalize medication selection and dosing based on your individual genetics.

Why I Believe GeneSight Is Valuable

As a psychiatric nurse practitioner, every medication decision involves balancing effectiveness, side effects, previous treatment history, medical conditions, and patient preferences.

GeneSight adds another layer of clinically useful information.

Instead of asking only, “What medication usually works for this diagnosis?” we can also ask, “Based on this patient’s genetics, are there medications that may be a better fit—or medications that deserve extra caution?”

That information can be incredibly helpful, particularly when patients have already tried several medications without success.

It’s Not About Replacing Clinical Judgment—It’s About Improving It

One of the biggest misconceptions about GeneSight is that it replaces the expertise of your psychiatric provider.

It doesn’t.

I don’t use GeneSight to let a computer choose medications.

I use it as another clinical tool—alongside a comprehensive psychiatric evaluation, your medical history, previous medication experiences, family history, current symptoms, and your treatment goals.

The best medication decisions come from combining good science with good clinical judgment.

What the Research Shows

Pharmacogenomic testing has been studied extensively over the past decade.

Large clinical trials have shown that using pharmacogenomic information to guide treatment can improve remission and response rates for many patients with major depressive disorder while reducing the likelihood of prescribing medications with significant gene-drug interactions.

The largest studies, including the GUIDED trial and the VA PRIME Care Trial, have demonstrated that pharmacogenomic testing can help clinicians make more informed prescribing decisions and improve outcomes for many patients, particularly those who have experienced unsuccessful medication trials in the past.

Like any medical test, GeneSight is one piece of the clinical picture—not the entire picture—but the growing body of evidence supporting pharmacogenomic-guided prescribing continues to expand.

Who Benefits Most?

In my experience, GeneSight can be especially helpful for patients who:

• Have tried multiple antidepressants without success.

• Experience significant medication side effects.

• Feel unusually sensitive to medications.

• Have a family history of medication difficulties.

• Want a more personalized approach to medication selection.

• Are starting psychiatric treatment and want additional information to help guide decisions.

Even when the results confirm what I was already considering, they often increase confidence in the treatment plan—for both my patients and me.

My Experience Over the Past 10 Years

Having worked with GeneSight for more than a decade, I’ve had the opportunity to see how pharmacogenomic testing has changed psychiatric practice.

I’ve consulted with healthcare providers, educated clinicians on interpreting GeneSight reports, and incorporated pharmacogenomic testing into my own clinical work with patients.

One of the things I’ve appreciated most is that the conversation has shifted from simply asking, “Which medication should we try next?” to asking, “Which medication is most likely to fit this individual patient?”

That represents an important step toward more personalized psychiatric care.

Is GeneSight Right for Everyone?

Not necessarily.

There are patients for whom GeneSight is extremely valuable, while others may not need testing.

During your evaluation, we’ll discuss your medication history, previous responses, and treatment goals to determine whether pharmacogenomic testing is likely to provide meaningful additional information.

When I recommend GeneSight, it’s because I believe it has the potential to improve the quality of your care—not because every patient automatically needs it.

The Bottom Line

Psychiatric medication should never be one-size-fits-all.

Every person brings a unique combination of genetics, medical history, life experiences, and treatment goals. GeneSight helps us better understand one important part of that equation.

After more than 10 years of working with pharmacogenomic testing—as both a GeneSight consultant and a psychiatric provider—I continue to view it as one of the most valuable tools available for personalizing psychiatric medication treatment. While it doesn’t eliminate every uncertainty, it often helps us make more informed decisions, avoid potential medication challenges, and move toward effective treatment with greater confidence.

How Open Road Psychiatric Services Can Help

At Open Road Psychiatric Services, we believe psychiatric care should be personalized. We offer comprehensive psychiatric evaluations, medication management, and GeneSight pharmacogenomic testing when clinically appropriate. By combining evidence-based medicine, clinical expertise, and individualized treatment planning, we strive to help every patient find the safest and most effective path toward better mental health.